LPATH, INC 4

Accession 0001179110-16-033594

CIK 0001251769operating

View on SEC.gov Company Profile

Filed

Dec 28, 7:00 PM ET

Accepted

Dec 29, 9:53 PM ET

Size

18.9 KB

Accession

0001179110-16-033594

Insider Transaction Report

Form 4

Period: 2016-12-29

LPATH, INCAPEN

McWilliams Dennis L.

President, CCO

Transactions

Other
Common Stock
2016-12-29+33,647→ 33,647 total
Other
Stock Options
2016-12-29+28,757→ 28,757 total
Exercise: $1.76Exp: 2017-09-17→ Common Stock (28,757 underlying)
Other
Stock Options
2016-12-29+54,808→ 54,808 total
Exercise: $3.36Exp: 2024-07-29→ Common Sock (54,808 underlying)
Other
Stock Options
2016-12-29+109,851→ 109,851 total
Exercise: $2.09Exp: 2022-04-26→ Common Stock (109,851 underlying)
Other
Stock Options
2016-12-29+28,757→ 28,757 total
Exercise: $1.76Exp: 2026-03-02→ Common Stock (28,757 underlying)
Other
Stock Options
2016-12-29+27,404→ 27,404 total
Exercise: $3.36Exp: 2024-07-29→ Common Stock (27,404 underlying)

Footnotes (6)

[F1]Shares of common stock of the corporation then known as Apollo Endosurgery, Inc. ("Old Apollo") were converted into shares of the Issuer pursuant to that certain Agreement and Plan of Merger and Reorganization, dated as of September 8, 2016, by and among the Issuer, Merger Sub, Inc. and Old Apollo (the "Merger Agreement"). Pursuant to the terms of the Merger Agreement, each share of common stock was converted into 0.3163 shares of the Issuer's common stock. Following the merger, the Issuer effected a reverse stock split at a ratio of one new share for every five and one half shares of common stock outstanding.
[F2]On September 18, 2007, Reporting Person was granted an option to purchase 500,000 shares of the common stock of Old Apollo under Old Apollo's Equity Incentive Plan at an exercise price of $0.10 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 28,757 shares of the Issuer's common stock at a per share exercise price of $1.76. The option has fully vested.
[F3]On April 27, 2012, Reporting Person was granted an option to purchase 1,910,000 shares of the common stock of Old Apollo under Old Apollo's Equity Incentive Plan at an exercise price of $0.12 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 109,851 shares of the Issuer's common stock at a per share exercise price of $2.09. The option has fully vested.
[F4]On July 30, 2014, Reporting Person was granted an option to purchase 952,965 shares of the common stock of Old Apollo under Old Apollo's Equity Incentive Plan at an exercise price of $0.19 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 54,808 shares of the Issuer's common stock at a per share exercise price of $3.36. Subject to Reporting Person's continued employment, 1/48th of the option will vest and become exercisable on each of the 48 months commencing on February 1, 2014. Upon a change of control of the Issuer, 100% of any unvested portion of the option will become fully vested and exercisable.
[F5]On July 30, 2014, Reporting Person was granted an option to purchase 476,483 shares of the common stock of Old Apollo under Old Apollo's Equity Incentive Plan at an exercise price of $0.19 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 27,404 shares of the Issuer's common stock at a per share exercise price of $3.36. Subject to Reporting Person's continued employment, 100% of the option will vest and become exercisable upon the Issuer's achievement of certain revenue milestones. Upon a change of control of the Issuer, 100% of any unvested portion of the option will become fully vested and exercisable.
[F6]On March 3, 2016, Reporting Person was granted an option to purchase 500,000 shares of the common stock of Old Apollo under Old Apollo's Equity Incentive Plan at an exercise price of $0.10 per share. Pursuant to the Merger Agreement, this option was converted into an option to purchase 28,757 shares of the Issuer's common stock at a per share exercise price of $1.76. Subject to Reporting Person's continued employment, 100% of the option will vest and become exercisable upon achievement of certain revenue targets. Upon a change of control of the Issuer, 100% of any unvested portion of the option will become fully vested and exercisable.

Documents

1 file

4
edgar.xmlPrimary
FORM 4 -

Issuer

LPATH, INC

CIK 0001251769

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0001251769

Filing Metadata

Form type: 4
Filed: Dec 28, 7:00 PM ET
Accepted: Dec 29, 9:53 PM ET
Size: 18.9 KB

View on SEC.gov